Ratio Examination: Soleno Therapeutics Inc (SLNO)’s Price-to-Cash and Price-to-Free Cash Flow

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Soleno Therapeutics Inc (NASDAQ: SLNO) closed at $48.14 down -6.72% from its previous closing price of $51.61. In other words, the price has decreased by -$6.72 from its previous closing price. On the day, 0.61 million shares were traded. SLNO stock price reached its highest trading level at $51.66 during the session, while it also had its lowest trading level at $48.09.

Ratios:

For a deeper understanding of Soleno Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 29.24 and its Current Ratio is at 29.24. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on September 03, 2024, initiated with a Buy rating and assigned the stock a target price of $70.

On May 10, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $72.

On February 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $93.Piper Sandler initiated its Overweight rating on February 05, 2024, with a $93 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 29 ’24 when Yen Kristen sold 5,435 shares for $47.28 per share. The transaction valued at 256,992 led to the insider holds 84,573 shares of the business.

Yen Kristen sold 5,270 shares of SLNO for $250,753 on Aug 28 ’24. The insider now owns 90,008 shares after completing the transaction at $47.58 per share. On Aug 29 ’24, another insider, Mackaness James H, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 6,870 shares for $47.28 each. As a result, the insider received 324,845 and left with 127,249 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLNO now has a Market Capitalization of 1871278848 and an Enterprise Value of 1605451520.

Stock Price History:

Over the past 52 weeks, SLNO has reached a high of $55.56, while it has fallen to a 52-week low of $3.96. The 50-Day Moving Average of the stock is -1.11%, while the 200-Day Moving Average is calculated to be 8.50%.

Shares Statistics:

For the past three months, SLNO has traded an average of 535.42K shares per day and 525770 over the past ten days. A total of 31.68M shares are outstanding, with a floating share count of 25.89M. Insiders hold about 33.39% of the company’s shares, while institutions hold 78.24% stake in the company. Shares short for SLNO as of 1724976000 were 4488691 with a Short Ratio of 8.38, compared to 1722384000 on 3960397. Therefore, it implies a Short% of Shares Outstanding of 4488691 and a Short% of Float of 18.72.

Most Popular